FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:128-129 July 11, 1996 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Effective medication for the treatment of cocaine overdose and addiction is a major unmet need of worldwide importance. In contrast to heroin, for which there are effective medications to treat both overdose (naloxone) and addiction (methadone), there are no pharmacologic treatments for any aspect of cocaine addiction. Recent discoveries indicating that an anti-cocaine medication is actually within reach are cause for great optimism. This work is defining specific molecular targets against which such a medication might be directed.

A recent study by Giros et al.¹ affirms the central importance of the dopamine-reuptake transporter in the behavioral and biochemical action of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Mendelson, J. H., Mello, N. K., Negus, S. S. (1999). Effects of Luteinizing Hormone-Releasing Hormone on Plasma Cocaine Levels in Rhesus Monkeys. J. Pharmacol. Exp. Ther. 289: 791-799 [Abstract] [Full Text]  
• Schuckit, M. A (1997). Science, medicine, and the future: Substance use disorders. BMJ 314: 1605-1605 [Full Text]